A randomized trial in the New England Journal compares therapeutic anticoagulation to standard prophylaxis in non-ICU patients with COVID-19.
<a href="https://journalclub.wustl.edu/2021/08/05/therapeutic-anticoagulation-with-heparin-in-noncritically-ill-patients-with-covid-19/">Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | Hospital Medicine Virtual Journal Club</a>

A randomized trial in the New England Journal compares therapeutic anticoagulation to standard prophylaxis in non-ICU patients with COVID-19. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | Hospital Medicine Virtual Journal Club

A randomized trial in the New England Journal compares therapeutic anticoagulation to standard prophylaxis in non-ICU patients with COVID-19.
<a href="https://journalclub.wustl.edu/2021/08/05/therapeutic-anticoagulation-with-heparin-in-noncritically-ill-patients-with-covid-19/" rel="noopener noreferrer">Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | Hospital Medicine Virtual Journal Club</a>

HMVJC Minute #29 - Anticoagulation in non-ICU COVID-19 patients: August 5, 2021

One article.
One minute.
100% evidence based.
From the Washington University Hospital Medicine Virtual Journal Club
https://journalclub.wustl.edu/

Medicine

Health & Fitness

One article. One minute. 100% evidence based. From the Washington University Hospital Medicine Virtual Journal Club https://journalclub.wustl.edu/

Share HMVJC Minute #29 - Anticoagulation in non-ICU COVID-19 patients: August 5, 2021

Sign up to save your podcasts

HMVJC Minute #29 - Anticoagulation in non-ICU COVID-19 patients: August 5, 2021

HMVJC Minute #29 - Anticoagulation in non-ICU COVID-19 patients: August 5, 2021